Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
Details for Australian Patent Application No. 2003269889 (hide)
International Classifications
Event Publications
15 January 2004 Complete Application Filed
Priority application(s): 60/389,242 17.06.02 US; 60/477,987 11.06.03 US
26 February 2004 Application Open to Public Inspection
Published as AU-B-2003269889
16 June 2005 Assignment before Grant
Epigenesis Pharmaceuticals, Inc. The application has been assigned to Epigenesis Pharmaceuticals, LLC.
19 April 2007 Application Accepted
Published as AU-B-2003269889
23 August 2007 Standard Patent Sealed
19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003269890-NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser